ES495412A0 - Procedimiento para la preparacion de derivados de n-fe- noxialcohilpiperidina - Google Patents

Procedimiento para la preparacion de derivados de n-fe- noxialcohilpiperidina

Info

Publication number
ES495412A0
ES495412A0 ES495412A ES495412A ES495412A0 ES 495412 A0 ES495412 A0 ES 495412A0 ES 495412 A ES495412 A ES 495412A ES 495412 A ES495412 A ES 495412A ES 495412 A0 ES495412 A0 ES 495412A0
Authority
ES
Spain
Prior art keywords
radical
group
tetrazol
hydroxyl
noxialcohilpiperidina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES495412A
Other languages
English (en)
Other versions
ES8105729A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES8105729A1 publication Critical patent/ES8105729A1/es
Publication of ES495412A0 publication Critical patent/ES495412A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES495412A 1979-09-28 1980-09-26 Procedimiento para la preparacion de derivados de n-fe- noxialcohilpiperidina Granted ES495412A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792939292 DE2939292A1 (de) 1979-09-28 1979-09-28 N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8105729A1 ES8105729A1 (es) 1981-06-16
ES495412A0 true ES495412A0 (es) 1981-06-16

Family

ID=6082088

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495412A Granted ES495412A0 (es) 1979-09-28 1980-09-26 Procedimiento para la preparacion de derivados de n-fe- noxialcohilpiperidina

Country Status (10)

Country Link
US (1) US4348401A (es)
EP (1) EP0026876B1 (es)
JP (1) JPS5668669A (es)
AT (1) ATE2519T1 (es)
CA (1) CA1139759A (es)
CS (1) CS219950B2 (es)
DD (1) DD153117A5 (es)
DE (2) DE2939292A1 (es)
ES (1) ES495412A0 (es)
IL (1) IL61114A0 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209271A1 (de) * 1982-03-13 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
HU215397B (hu) * 1994-08-29 1998-12-28 Richter Gedeon Vegyészeti Gyár Rt. (Piperidino-alkil)-aril-éterek, ezeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
IL164007A0 (en) 2002-03-13 2005-12-18 Janssen Pharmaceutica Nv New inhibitors of histone deacetylase
BR0307599A (pt) 2002-03-13 2005-02-01 Janssen Pharmaceutica Nv Derivados de sulfonilamino como inibidores de histona deacetilase
ATE398105T1 (de) * 2002-03-13 2008-07-15 Janssen Pharmaceutica Nv Carbonylamino- derivativate als neue inhibitoren von histone deacetylase
ES2307909T3 (es) * 2002-03-13 2008-12-01 Janssen Pharmaceutica Nv Derivados de piperazinil, piperidinil y morfolinil como nuevos inhidbidores de la histona deacetilasa.
MX2007001120A (es) 2004-07-28 2007-03-15 Janssen Pharmaceutica Nv Derivados de indolil alquil sustituidos como nuevos inhibidores de la histona desacetilasa.
RU2396955C2 (ru) * 2005-04-07 2010-08-20 Тояма Кемикал Ко., Лтд. Фармацевтическая комбинация и способ применения противогрибкового средства в комбинации
EP1885710B1 (en) 2005-05-18 2015-08-19 Janssen Pharmaceutica N.V. Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
DE602007001190D1 (de) * 2006-01-19 2009-07-09 Janssen Pharmaceutica Nv Aminophenylderivate als neue inhibitoren von histondeacetylase
JP5137849B2 (ja) * 2006-01-19 2013-02-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしての置換インドリル−アルキル−アミノ−誘導体
US8114876B2 (en) 2006-01-19 2012-02-14 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
US8101616B2 (en) * 2006-01-19 2012-01-24 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
MX2008014450A (es) 2006-05-18 2009-03-09 Mannkind Corp Inhibidores de cinasa intracelular.
KR102077864B1 (ko) 2012-08-01 2020-02-14 쇼와 덴코 패키징 가부시키가이샤 내용물 부착 방지 덮개재

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255196A (en) * 1966-06-07 Phenoxyalkyl piperidine derivatives
CH411880A (fr) * 1962-02-28 1966-04-30 Rhone Poulenc Sa Procédé de préparation de nouveaux dérivés de la pipéridine
US3691176A (en) * 1970-05-25 1972-09-12 Abbott Lab 1-(4-fluorophenoxypropyl)-4-anilino-piperidines
DE2341376A1 (de) * 1972-08-24 1974-03-07 Ciba Geigy Ag Piperidin-derivate und verfahren zu ihrer herstellung
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions
DE2737630A1 (de) * 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPS5668669A (en) 1981-06-09
DE2939292A1 (de) 1981-04-09
EP0026876A1 (de) 1981-04-15
EP0026876B1 (de) 1983-02-16
ES8105729A1 (es) 1981-06-16
US4348401A (en) 1982-09-07
ATE2519T1 (de) 1983-03-15
DE3062052D1 (en) 1983-03-24
CS219950B2 (en) 1983-03-25
DD153117A5 (de) 1981-12-23
IL61114A0 (en) 1980-11-30
CA1139759A (en) 1983-01-18

Similar Documents

Publication Publication Date Title
ES495412A0 (es) Procedimiento para la preparacion de derivados de n-fe- noxialcohilpiperidina
ES2032750T3 (es) Profarmacos de rapamicina.
DK0565377T3 (da) Terapeutiske midler til behandling af Parkinsons sygdom
EA200501104A1 (ru) Производные пиридина, пригодные для ингибирования системы обмена натрия/кальция
SE8000205L (sv) Nya heterotricykliska derivat, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa derivat
AU572690B2 (en) Tricyclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them
PT74199A (de) Neue trisubstituierte pyrimido<5,4-d>pyrimidine ihre herstel- lung und ihre verwendung als arzneimittel
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
ES519153A0 (es) Procedimiento de preparacion de nuevos derivados de la benzodioxina y de sus sales de adicion acida.
AU556922B2 (en) Pyridobenzodiazepinone derivatives
DK373783D0 (da) Thieno-thiazol-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
ATE88467T1 (de) Pharmakologisch aktive alkylol-derivate.
SE8007025L (sv) Derivat av 1,2,4-oxadiazolin-5-on, sett for deras framstellning och farmaceutiska beredningar innehallande dem
DE3587653T2 (de) Sparsomycinderivate.
DE69124017D1 (de) Heterocyclische Derivate
ES519530A0 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES2154191A1 (es) Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
ES465221A1 (es) Procedimiento para la preparacion de nuevos derivados de 4- ter-buti-3'-clorodifenilamina con actividad antihistaminica.